A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
- Status
- RECRUITING
- Phase
- PHASE3
Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
- Status
- RECRUITING
- Phase
- PHASE2
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- Status
- RECRUITING
- Phase
- PHASE3
Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
EVR and EPO for Liver Transplant Tolerance
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
RESTOR: PK/PD mTORi Inhibition in Older Adults
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients
- Status
- RECRUITING
- Phase
- PHASE4
Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
- Status
- RECRUITING
- Phase
- PHASE2
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
- Status
- RECRUITING
- Phase
- PHASE3
Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2